Average Co-Inventor Count = 1.87
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Other (16 from 832,843 patents)
2. Regeneron Pharmaceuticals, Inc. (15 from 1,343 patents)
3. Sanofi Biotechnology (10 from 37 patents)
4. Puradyn Filter Technologies, Inc. (1 from 6 patents)
32 patents:
1. 12398212 - Methods for treating or preventing asthma by administering an IL-4R antagonist
2. 12090201 - Methods for treating atopic dermatitis by administering an IL-4R antagonist antibody
3. 11845800 - Methods for treating or preventing asthma by administering an IL-4R antagonist
4. 11603408 - Methods for treating skin infection by administering an IL-4R antagonist
5. 11485788 - Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R inhibitor
6. 11319375 - Methods and compositions for treating subjects having rheumatoid arthritis
7. 11167004 - Methods for treating severe atopic dermatitis by administering an IL-4R inhibitor
8. 11034768 - Methods for treating or preventing asthma by administering an IL-4R antagonist
9. 10676530 - Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an antibody to IL-4 receptor
10. 10669341 - Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an antibody to IL-4 receptor
11. 10485844 - Methods for treating severe atopic dermatitis by administering an IL-4R inhibitor
12. 10392439 - Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R inhibitor
13. 10370449 - Methods for treating skin infection by administering an IL-4R antagonist
14. 10314904 - Methods for enhancing efficacy of a vaccine by administering an IL-4R antagonist
15. 10137193 - Methods for treating or preventing asthma by administering an IL-4R antagonist